Patent ID: 11958903
Assignee: NANJING LEGEND BIOTECH CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 19:
20. The anti-LAG-3 construct of claim 12, comprising
(a) a first polypeptide having the amino acid of SEQ ID NO: 441, and a second polypeptide having the amino acids of SEQ ID NO: 442;
(b) a first polypeptide having the amino acid of SEQ ID NO: 433, and a second polypeptide having the amino acids of SEQ ID NO: 434;
(c) a first polypeptide having the amino acid of SEQ ID NO: 403, and a second polypeptide having the amino acids of SEQ ID NO: 404;
(d) a first polypeptide having the amino acid of SEQ ID NO: 411, and a second polypeptide having the amino acids of SEQ ID NO: 412;
(e) a first polypeptide having the amino acid of SEQ ID NO: 381, and a second polypeptide having the amino acids of SEQ ID NO: 382;
(f) a first polypeptide having the amino acid of SEQ ID NO: 377, and a second polypeptide having the amino acids of SEQ ID NO: 378;
(g) a first polypeptide having the amino acid of SEQ ID NO: 379, and a second polypeptide having the amino acids of SEQ ID NO: 380;
(h) a first polypeptide having the amino acid of SEQ ID NO: 375, and a second polypeptide having the amino acids of SEQ ID NO: 376;
(i) a first polypeptide having the amino acid of SEQ ID NO: 383, and a second polypeptide having the amino acids of SEQ ID NO: 384;
(j) a first polypeptide having the amino acid of SEQ ID NO: 385, and a second polypeptide having the amino acids of SEQ ID NO: 386;
(k) a first polypeptide having the amino acid of SEQ ID NO: 387, and a second polypeptide having the amino acids of SEQ ID NO: 388;
(l) a first polypeptide having the amino acid of SEQ ID NO: 389, and a second polypeptide having the amino acids of SEQ ID NO: 390;
(m) a first polypeptide having the amino acid of SEQ ID NO:391, and a second polypeptide having the amino acids of SEQ ID NO: 392;
(n) a first polypeptide having the amino acid of SEQ ID NO: 393, and a second polypeptide having the amino acids of SEQ ID NO: 394;
(o) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 395, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 396;
(p) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 397, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 398;
(q) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 399, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 400;
(r) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 401, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 402;
(s) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 405, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 406;
(t) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 407, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 408;
(u) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 409, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 410;
(v) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 413, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 414;
(w) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 415, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 416;
(x) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 417, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 418;
(y) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 419, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 420;
(z) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 421, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 422;
(aa) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 423, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 424;
(bb) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 425, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 426;
(cc) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 427, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 428;
(dd) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 429, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 430;
(ee) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 431, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 432;
(ff) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 435, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 436;
(gg) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 437, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 438;
(hh) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 439, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 440;
(ii) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 443, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 444; or
(jj) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 445, and a second polypeptide comprising the amino acid sequence of SEQ ID NO: 446.